Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | GFER | P55789 | 1/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.57 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364785 | 1.00 | KEAP1 (1.00) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL9000281 | 0.98 | KEAP1 (0.96) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| Hydrochloric Acid SCHEMBL9653956 | 0.98 | KEAP1 (0.96) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| Nitrogen SCHEMBL28928291 | 0.96 | KEAP1 (0.92) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL2789012 | 0.84 | KMT2A (0.78) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL183930 | 0.83 | KEAP1 (0.70) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL31230207 | 0.83 | KEAP1 (0.70) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL25958 | 0.83 | KEAP1 (0.70) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL9118879 | 0.81 | KEAP1 (0.66) | KEAP1KDM4EKMT2AGFERRXFP1 | |
| SCHEMBL9665493 | 0.81 | KEAP1 (0.68) | KEAP1KDM4EKMT2AGFERRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1838 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| CN-119464351-A | Method for improving CRISPR-Cas gene editing efficiency of yeast | 大连理工大学 | 2025-02-18 | — | — | CN | claimed |
| US-20240011009-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2024-01-11 | — | — | US | claimed |
| US-20230349872-A1 | GUN SHOT RESIDUE FIELD KIT | VERITEQUE USA, INC. | 2023-11-02 | — | — | US | claimed |
| US-20230340539-A1 | METHODS OF TRANSIENT PROTEIN AND GENE EXPRESSION IN CELLS | ZYMERGEN INC. | 2023-10-26 | — | — | US | claimed |
| CN-115010671-B | One-step synthesis method of 2-substituted quinazolinone | 江苏大学 | 2023-10-10 | — | — | CN | claimed |
| US-11718820-B2 | Genetically modified haploid Issatchenkia orientalis | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | claimed |
| US-20230220589-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2023-07-13 | — | — | US | claimed |
| CN-116283803-A | Preparation method of flumazenil intermediate | 上海旭东海普药业有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4182657-A1 | GUN SHOT RESIDUE FIELD KIT | Veriteque USA, Inc. (US) | 2023-05-24 | — | — | EP | claimed |
| US-6756486-B1 | LAKED DISAZO YELLOW PIGMENTS HAVING DESIRABLE GREEN SHADE, HEAT STABILITY, GOOD STRENGTH, BLEED RESISTANCE, MIGRATION RESISTANCE, AND LOW OR NO TOXICITY | ENGELHARD CORPORATION | 2004-06-29 | — | — | US | claimed |
| CN-1477097-A | Preparation method of 2-amino-5-fluorobenzoic acid | 华东理工大学 | 2004-02-25 | — | — | CN | claimed |
| CN-1477099-A | O-pyridinoquinone derivative, composition containing the same, preparation method and use of the same | 百瑞全球有限公司 | 2004-02-25 | — | — | CN | claimed |
| EP-0647614-B1 | Process for the préparation of 5-fluoro anthranilic acid | HOECHST AG (DE) | 1997-06-04 | — | — | EP | claimed |
| EP-0647615-B1 | Process for the preparation of 5-fluoroanthranilic acid alkyl esters and or 5-fluoroanthranilic acid | HOECHST AG (DE) | 1997-05-28 | — | — | EP | claimed |
| US-5543550-A | NITRATING ALKYL ESTER OF 3-FLUOROBENZOIC ACID DISSOLVED IN SOLVENT-FREE SULFURIC ACID, THEN ADDING WATER, SEPARATION, HYDROLYSIS, PRESSURIZED CATALYTIC HYDROGENATION OF THE NITRATED ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-06 | — | — | US | claimed |
| US-5523472-A | Process for the preparation of 5-fluoroanthranilic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-04 | — | — | US | claimed |
| EP-0700895-A2 | Process for the selective preparation of fluorinated aromatic amines and fluorinated aromatic amines with particularly low contents of defluorinated portions | BAYER AG (DE) | 1996-03-13 | — | — | EP | claimed |
| EP-0647614-A1 | Process for the préparation of 5-fluoro anthranilic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-04-12 | — | — | EP | claimed |
| EP-0647615-A1 | Process for the preparation of 5-fluoroanthranilic acid alkyl esters and or 5-fluoroanthranilic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-04-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718820-B2 | Genetically modified haploid Issatchenkia orientalis | DERA, HOGA1, IPMK | KEAP1 1092/4885KDM4E 2991/4885KMT2A 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.